Engineering Affinity Windows to Balance Potency, Safety & Durability in Bispecifics & T-Cell Engagers

  • Designing optimal affinity windows across tumor and CD3 arms to drive effective synapse formation, while avoiding excessive T-cell activation and offtumor toxicity
  • Understanding how affinity tuning influences serial killing, T-cell exhaustion, and durability of the response, particularly in solid tumor settings
  • Applying affinity engineering strategies early in bispecific and T-cell engager design to improve clinical predictability and reduce downstream safety and development risk